Jörn Weisner

703 total citations
20 papers, 426 citations indexed

About

Jörn Weisner is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jörn Weisner has authored 20 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Jörn Weisner's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Click Chemistry and Applications (4 papers) and Quinazolinone synthesis and applications (4 papers). Jörn Weisner is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Click Chemistry and Applications (4 papers) and Quinazolinone synthesis and applications (4 papers). Jörn Weisner collaborates with scholars based in Germany, South Africa and United States. Jörn Weisner's co-authors include Daniel Rauh, Matthias Müller, Niklas Uhlenbrock, Laura Depta, Rajesh Gontla, Petra Janning, Sebastian Bauer, Kristina Althoff, Willem A. L. van Otterlo and Jens T. Siveke and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and PLoS ONE.

In The Last Decade

Jörn Weisner

20 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörn Weisner Germany 11 278 145 64 63 43 20 426
Shendong Yuan United States 11 253 0.9× 176 1.2× 44 0.7× 88 1.4× 19 0.4× 20 524
Klaus Urbahns Germany 15 283 1.0× 173 1.2× 30 0.5× 192 3.0× 61 1.4× 27 683
Andrea Missio Italy 8 344 1.2× 139 1.0× 20 0.3× 75 1.2× 62 1.4× 10 499
Laura A. Lopez-Garcia Germany 13 517 1.9× 109 0.8× 35 0.5× 73 1.2× 16 0.4× 16 629
Mingsong Shi China 14 261 0.9× 131 0.9× 20 0.3× 114 1.8× 11 0.3× 58 470
Nemanja Djoković Serbia 10 190 0.7× 88 0.6× 56 0.9× 41 0.7× 40 0.9× 17 294
James R. Porter United States 8 350 1.3× 60 0.4× 24 0.4× 59 0.9× 23 0.5× 12 483
Eliud Hernandez O'Farril Puerto Rico 15 412 1.5× 246 1.7× 27 0.4× 124 2.0× 19 0.4× 31 755
Peter Chua Canada 11 443 1.6× 323 2.2× 22 0.3× 111 1.8× 33 0.8× 14 766
Angela Vaasa Estonia 12 288 1.0× 130 0.9× 67 1.0× 59 0.9× 10 0.2× 15 364

Countries citing papers authored by Jörn Weisner

Since Specialization
Citations

This map shows the geographic impact of Jörn Weisner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörn Weisner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörn Weisner more than expected).

Fields of papers citing papers by Jörn Weisner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörn Weisner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörn Weisner. The network helps show where Jörn Weisner may publish in the future.

Co-authorship network of co-authors of Jörn Weisner

This figure shows the co-authorship network connecting the top 25 collaborators of Jörn Weisner. A scholar is included among the top collaborators of Jörn Weisner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörn Weisner. Jörn Weisner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gontla, Rajesh, Thomas Mühlenberg, Jörn Weisner, et al.. (2024). Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA. Nature Communications. 15(1). 63–63. 16 indexed citations
2.
Weisner, Jörn, et al.. (2024). Synthesis of Asymmetric Ionic Hybrid Detergents enables Micelles with Scalable Properties including Cell Compatibility. Chemistry - A European Journal. 30(45). e202401833–e202401833. 5 indexed citations
3.
Weisner, Jörn, et al.. (2024). Akt Inhibitor Advancements: From Capivasertib Approval to Covalent-Allosteric Promises. Journal of Medicinal Chemistry. 67(8). 6052–6063. 19 indexed citations
4.
Weisner, Jörn, et al.. (2023). Insights into the Conformational Plasticity of the Protein Kinase Akt1 by Multi‐Lateral Dipolar Spectroscopy. Chemistry - A European Journal. 29(24). e202203959–e202203959. 4 indexed citations
5.
Depta, Laura, Jörn Weisner, Stefano Tomassi, et al.. (2022). Design and synthesis of Nrf2-derived hydrocarbon stapled peptides for the disruption of protein-DNA-interactions. PLoS ONE. 17(6). e0267651–e0267651. 7 indexed citations
6.
Weisner, Jörn, Rajesh Gontla, Christiane Ehrt, et al.. (2022). A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2. RSC Medicinal Chemistry. 13(12). 1540–1548. 2 indexed citations
7.
Weisner, Jörn, Abu Taher, Niklas Uhlenbrock, et al.. (2022). Covalent Allosteric Inhibitors of Akt Generated Using a Click Fragment Approach. ChemMedChem. 17(10). e202100776–e202100776. 6 indexed citations
8.
Depta, Laura, Niklas Uhlenbrock, Jörn Weisner, et al.. (2021). Cellular model system to dissect the isoform-selectivity of Akt inhibitors. Nature Communications. 12(1). 5297–5297. 32 indexed citations
9.
Lategahn, Jonas, Marina Keul, Hannah L. Tumbrink, et al.. (2020). Targeting Her2-insYVMA with Covalent Inhibitors—A Focused Compound Screening and Structure-Based Design Approach. Journal of Medicinal Chemistry. 63(20). 11725–11755. 12 indexed citations
10.
Weisner, Jörn, et al.. (2020). Conformational selection vs. induced fit: insights into the binding mechanisms of p38α MAP Kinase inhibitors. Chemical Communications. 56(62). 8818–8821. 8 indexed citations
11.
Uhlenbrock, Niklas, Steven P. Smith, Jörn Weisner, et al.. (2019). Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt. Chemical Science. 10(12). 3573–3585. 52 indexed citations
12.
Weisner, Jörn, Matthias Müller, C. Pichlo, et al.. (2019). 2-Azo-, 2-diazocine-thiazols and 2-azo-imidazoles as photoswitchable kinase inhibitors: limitations and pitfalls of the photoswitchable inhibitor approach. Photochemical & Photobiological Sciences. 18(6). 1398–1407. 62 indexed citations
13.
Depta, Laura, Jörn Weisner, Niklas Uhlenbrock, et al.. (2019). Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity. Angewandte Chemie International Edition. 58(52). 18823–18829. 54 indexed citations
14.
Depta, Laura, Jörn Weisner, Niklas Uhlenbrock, et al.. (2019). Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity. Angewandte Chemie. 131(52). 18999–19005. 6 indexed citations
15.
Weisner, Jörn, et al.. (2018). Chemical modulation of transcription factors. MedChemComm. 9(8). 1249–1272. 9 indexed citations
16.
Weisner, Jörn, et al.. (2018). Direct monitoring of the conformational equilibria of the activation loop in the mitogen-activated protein kinase p38α. Chemical Communications. 54(85). 12057–12060. 10 indexed citations
17.
Weisner, Jörn, et al.. (2018). RASPELD to Perform High‐End Screening in an Academic Environment toward the Development of Cancer Therapeutics. ChemMedChem. 13(19). 2065–2072. 5 indexed citations
18.
Weisner, Jörn, et al.. (2017). Covalent Lipid Pocket Ligands Targeting p38α MAPK Mutants. Angewandte Chemie International Edition. 56(43). 13232–13236. 14 indexed citations
19.
Weisner, Jörn, Rajesh Gontla, Sebastian Oeck, et al.. (2015). Covalent‐Allosteric Kinase Inhibitors. Angewandte Chemie International Edition. 54(35). 10313–10316. 87 indexed citations
20.
Weisner, Jörn, Rajesh Gontla, Sebastian Oeck, et al.. (2015). Kovalent‐allosterische Kinase‐Inhibitoren. Angewandte Chemie. 127(35). 10452–10456. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shendong Yuan Breakdown of academic impact, for papers by Klaus Urbahns Breakdown of academic impact, for papers by Andrea Missio Breakdown of academic impact, for papers by Laura A. Lopez-Garcia Breakdown of academic impact, for papers by Mingsong Shi Breakdown of academic impact, for papers by Nemanja Djoković Breakdown of academic impact, for papers by James R. Porter Breakdown of academic impact, for papers by Eliud Hernandez O'Farril Breakdown of academic impact, for papers by Peter Chua Breakdown of academic impact, for papers by Angela Vaasa
Rankless by CCL
2026